Pierre Fabre S.A. is headquartered in Paris, France.
Pierre Fabre S.A. has 8,620 employees.
Pierre Fabre S.A. is a life science company.
12 Avenue Hoche,
Paris,
75008
France,
+33 5 63 62 38 50
www.pierre-fabre.com
The Pierre Fabre Group, the second largest independent laboratory in France made Research and Development its core business and the key to its future. Pierre Fabre invests 25% of its annual sales to R&D, in five major therapeutic areas in terms of public health: oncology (the priority R&D area of Pierre Fabre Médicament, with 50% of all R&D expenses), central nervous system, cardiology, internal medicine/urology, dermatology.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.2/yr) | # | 2 | - | - | 1 | - | - | 3 |
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 3 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
